Correct Understanding of Side Effects of Aspirin

doi:10.3969/j.issn.1007-9572.2016.32.001

Abstract

Abstract: This paper introduces the side effects related with aspirin and the corresponding prevention and treatment strategies.By having those correct knowledge and taking effective prevention strategies and standardizing use of aspirin,the side effects can be preventable and patients can get maximization of benefits.

Key words: Aspirin, Drug toxicity, Review

摘要： 为了提高对阿司匹林不良反应的正确认识，避开临床使用误区，本文简述了阿司匹林常见及罕见的不良反应，以及相应的预防和处理策略。正确认识阿司匹林不良反应，有效进行预防并规范使用阿司匹林，可以降低阿司匹林不良反应的发生，并使获益最大化。

关键词: 阿司匹林, 药物毒性, 综述

WANG Fang. Correct Understanding of Side Effects of Aspirin[J]. Chinese General Practice, 2016, 19(32): 3897-3901.

汪芳. 正确认识阿司匹林的不良反应[J]. 中国全科医学, 2016, 19(32): 3897-3901.

References

［1］YEOMANS N D,LANAS A I,TALLEY N J,et al.Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin［J］.Aliment Pharmacol Ther，2005，22（9）：795-801. ［2］Final report on the aspirin component of the ongoing Physicians’ Health Study.Steering Committee of the Physicians’ Health Study Research Group［J］.N Engl J Med,1989,321（3）：129-135. ［3］MCQUAID K R,LAINE L.Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials［J］.Am J Med，2006，119（8）：624-638. ［4］抗血小板药物消化道损伤的预防和治疗中国专家共识组.抗血小板药物消化道损伤的预防和治疗中国专家共识（2012更新版）［J］.中华内科杂志，2013，52（3）：264-270. ［5］TARNAWSKI A S,AHLUWALIA A,JONES M K.The mechanisms of gastric mucosal injury:focus on microvascular endothelium as a key target［J］.Curr Med Chem，2012，19（1）：4-15. ［6］TULASSAY Z,HERSZNYI L.Gastric mucosal defense and cytoprotection［J］.Best Pract Res Clin Gastroenterol，2010，24（2）：99-108. ［7］SEREBRUANY V L,MALININ A I,EISERT R M,et al.Risk of bleeding complications with antiplatelet agents:meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials［J］.Am J Hematol，2004，75（1）：40-47. ［8］CAPRIE Steering Committee.A randomised,blinded,trial of clopidogrel versus aspirin in patients at risk of ischaemic events（CAPRIE）.CAPRIE Steering Committee ［J］.Lancet，1996，348（9038）：1329-1339. ［9］LANAS A,GARCIA-RODRIGUEZ L A,ARROYO M T,et al.Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors,traditional non-aspirin non-steroidal anti-inflammatory drugs,aspirin and combinations［J］.Gut，2006，55（12）：1731-1738. ［10］张万岱,胡伏莲,萧树东,等.中国自然人群幽门螺杆菌感染的流行病学调查［J］.现代消化及介入诊疗，2010，15（5）：265-270. ZHANG W D,HU F L,XIAO S D,et al.Prevalence of Helicobacter pylori infection in China［J］.Modern Digestion & Intervention，2010，15（5）：265-270. ［11］HALLAS J,DALL M,ANDRIES A,et al.Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding:population based case-control study［J］.BMJ，2006，333（7571）：726. ［12］VALKHOFF V E,STURKENBOOM M C,KUIPERS E J.Risk factors for gastrointestinal bleeding associated with low-dose aspirin［J］.Best Pract Res Clin Gastroenterol，2012，26（2）：125-140. ［13］TAHA A S,ANGERSON W J,PRASAD R,et al.Clinical trial:the incidence and early mortality after peptic ulcer perforation,and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs［J］.Aliment Pharmacol Ther，2008，28（7）：878-885. ［14］张大真,权正良,李增烈.长期服用小剂量肠溶型阿司匹林对胃十二指肠黏膜损害的病例对照研究［J］.胃肠病学，2006，11（7）：427-430. ZHANG D Z,QUAN Z L,LI Z L.Effects of long-term,low-dose,enteric-coated aspirin on gastroduodenal mucosa:a case-control study［J］.Chinese Journal of Gastroenterology，2006，11（7）：427-430. ［15］CHAN F K,CHING J Y,HUNG L C,et al.Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding［J］.N Engl J Med，2005，352（3）：238-244. ［16］抗栓治疗消化道损伤防治专家组.抗栓治疗消化道损伤防治中国专家建议（2016·北京）［J］.中华内科杂志，2016，55（7）：564-567. ［17］HE J,WHELTON P K,VU B,et al.Aspirin and risk of hemorrhagic stroke:a meta-analysis of randomized controlled trials［J］.JAMA，1998，280（22）：1930-1935. ［18］中华医学会心血管病学分会,中华心血管病杂志编辑委员会.抗血小板治疗中国专家共识［J］.中华心血管病杂志，2013，41（3）：183-194. ［19］曲良锁,毛涌馨,张文怡,等.长期服用阿司匹林的脑出血患者急症手术治疗［J］.中华神经外科疾病研究杂志，2015，14（1）：33-36. QU L S,MAO Y X,ZHANG W Y,et al.Emergency surgical treatment for intracerebral hemorrhage in patients underwent long term aspirin therapy［J］.Chinese Journal of Neurosurgical Disease Research，2015，14（1）：33-36. ［20］Antithrombotic Trialists’（ATT） Collaboration,BAIGENT C,BLACKWELL L,et al.Aspirin in the primary and secondary prevention of vascular disease:collaborative meta-analysis of individual participant data from randomized trials［J］.Lancet，2009，373（9678）:1849-1860. ［21］吴冰冰,梅琼.阿司匹林不良反应的国内文献分析［J］.中国药师，2008，11（2）：224-225. ［22］刘剩勇,马晓海.阿司匹林临床新用及常见不良反应［J］.中国医药指南，2011，9（33）：37-39. ［23］新怡康.普通阿司匹林、阿司匹林肠溶片临床应用胃肠道不良反应的比较［J］.临床和实验医学杂志，2006，5（8）：1201. ［24］UEMURA N,SUGANO K,HIRAISHI H,et al.Risk factor profiles,drug usage,and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients:the results from the MAGIC study［J］.J Gastroenterol，2014，49（5）：814-824. ［25］Antithrombotic Trialists’ Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients［J］.BMJ，2002，324（7329）：71-86. ［26］中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心血管病预防指南［J］.中华心血管病杂志，2011，39（1）：3-22. Chinese Society of Cardiology of Chinese Medical Association,Editorial Board of Chinese Journal of Cardiology.Chinese guidelines for prevention of cardiovascular diseases［J］.Chinese Journal of Cardiology，2011，39（1）：3-22. ［27］BIBBINS-DOMINGO K,U.S.Preventive Services Task Force.Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer:U.S.Preventive Services Task Force Recommendation Statement［J］.Ann Intern Med，2016，164（12）：836-845. ［28］赵艳杰,卫建光.阿司匹林肠溶片服用时间的探讨［J］.中国实用医药，2011，6（34）：139-140. ［29］练新飞,向定成.服药时间对肠溶阿司匹林胃肠道副作用的影响［J］.中国煤炭工业医学杂志，2005，8（5）：457-458. ［30］GARCA RODRGUEZ L A,CEA SORIANO L,HILL C,et al.Increased risk of stroke after discontinuation of acetylsalicylic acid:a UK primary care study［J］.Neurology，2011，76（8）：740-746. ［31］BIONDI-ZOCCAI G G,LOTRIONTE M,AGOSTONI P,et al.A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease［J］.Eur Heart J，2006，27（22）：2667-2674. ［32］CEA SORIANO L,BUENO H,LANAS A,et al.Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation［J］.Thromb Haemost，2013，110（6）：1298-1304. ［33］GARCA-RODRGUEZ L A,GAIST D,MORTON J,et al.Antithrombotic drugs and risk of hemorrhagic stroke in the general population［J］.Neurology，2013，81（6）：566-574. ［34］ROTHWELL P M,PRICE J F,FOWKES F G,et al.Short-term effects of daily aspirin on cancer incidence,mortality,and non-vascular death:analysis of the time course of risks and benefits in 51 randomised controlled trials［J］.Lancet，2012，379（9826）：1602-1612. ［35］EIKELBOOM J W,HIRSH J,SPENCER F A,et al.Antiplatelet drugs:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines［J］.Chest，2012，141（2 Suppl）：e89S-119S.

[1]	XIANG Tianle, ZHOU Na, LI Fang, CAO Meijuan. Research Progress on Assessment Methods of 24-hour Movement Behaviors in Children [J]. Chinese General Practice, 2026, 29(06): 760-766.
[2]	WANG Lina, LEI Jingshu, LI Kuibao, WANG Ruiying, LI Xinmiao, WANG Fangfang, GUO Xiaorong, NIU Ruihao, ZHAO Wei, ZHOU Fangfang, ZHAO Jingjing, LEE CHONGYOU. Review on Inflammatory Response in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2026, 29(06): 790-801.
[3]	SHI Jiaqi, WANG Yuxin, LUO Jiani, JIANG Qi, WU Shanyu, JIN Toufeng. Factors Influencing Symptom Clusters in Patients with Gastrointestinal Cancers: a Scoping Review [J]. Chinese General Practice, 2026, 29(05): 668-675.
[4]	TIAN Ziwei, YANG Zhilan, ZHAO Huimin, ZHAI Yanping, LI Hongyan, DU Miao, JIN Yuanyuan, SONG Zeyu. Frailty in Patients with Knee Osteoarthritis: a Scoping Review [J]. Chinese General Practice, 2026, 29(05): 676-680.
[5]	CAO Xinyang, WANG Yang, JIN Hua, YU Dehua, YANG Hui, LIU Xiaoyun, XU Yanli. Factors Influencing the Development of Research Capabilities in General Practice: a Scoping Review [J]. Chinese General Practice, 2026, 29(04): 444-456.
[6]	WANG Yiheng, XU Xiaoming, XIA Yunlong, XIA Linying, HAN Xue, GUO Yongzhen, LIU Quanchi, YAN Wenjun. Progress in Pharmacotherapy of Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2026, 29(03): 403-408.
[7]	JIANG Xiaorui, YAN Yuyao, WEI Jingjing, QIAO Lijie, PENG Guangcao, ZHU Mingjun. Systematic Review of Risk Prediction Models for Concurrent Heart Failure with Coronary Heart Disease [J]. Chinese General Practice, 2026, 29(03): 393-402.
[8]	LIU Yan, YUAN Yanling, LING Rong, WANG Lanyun, SUN Li. Scoping Review of Telemedicine Application in Cardiac Rehabilitation for Coronary Heart Disease Patients [J]. Chinese General Practice, 2025, 28(36): 4640-4647.
[9]	SUN Jiaying, ZHOU Pengxiang, XIA Yu, YAN Ming, ZHOU Xinmei, WU Lingyan, TONG Yuling, ZHAO Yang, XU Zhijie. Interpretation of a Position Statement from an Italian Scientific Consortium: Medication Review and Deprescribing [J]. Chinese General Practice, 2025, 28(36): 4550-4557.
[10]	WANG Yi, CHENG Jinxiang, ZHAO Xianchao, REN Jiafeng, ZHANG Liping, DONG Menglong, LIN Zhifeng, SU Changjun. Research Progress on Drug-related Rapid Eye Movement Sleep Behavior Disorder [J]. Chinese General Practice, 2025, 28(35): 4511-4516.
[11]	LI Mingyue, TANG Haoqing, ZHENG Huixian, ZHANG Xiaotian, LIU Xiaoyun. Exploring the Concept of the Quality of Primary Health Care: a Systematic Review [J]. Chinese General Practice, 2025, 28(34): 4300-4310.
[12]	HUANG Xintao, CHEN Mo, WANG Junyu, ZHANG Chen, DENG Huisheng. Research on Education of Rural-oriented Medical Students in China: a Systematic Review [J]. Chinese General Practice, 2025, 28(34): 4290-4299.
[13]	HE Yuling, LIN Meiqun, LUO Huiyu, HUANG Wenting, JIANG Liqin, ZHU Hongyu. Systematic Review of Guidelines for the Management of Patients with Cancer Pain [J]. Chinese General Practice, 2025, 28(33): 4199-4205.
[14]	WANG Mengqi, LIANG Moxuan, LI Zeyuan, GUO Yuting, CHENG Jingmin. Effectiveness of Intermittent Fasting in Patients with Type 2 Diabetes Mellitus: a Scoping Review [J]. Chinese General Practice, 2025, 28(33): 4234-4240.
[15]	GAO Jiaxin, ZHOU Ruihan, WANG Fangfang, PANG Rizhao, ZHANG Anren. Advances in Dietary Restriction on the Regulation of Organismal Immune Function [J]. Chinese General Practice, 2025, 28(32): 4102-4109.